In In Re: Nordt Development Co., the CAFC vacated the Board’s finding that the claim term “injection molded” was a product-by-process limitation that was not afforded patentable weight.
Claim 1 includes many instances of …
Read More
In Owens Corning v. Fast Felt Corporation (decided October 11, 2017), the Court of Appeals for the Federal Circuit held that the Patent Trial and Appeal Board’s finding that obviousness was not proven in an inter parte revie…
Read More
In In Re: Smith International, Inc., the CAFC held that the broadest reasonable interpretation of a claim term must correspond with what and how the inventor describes the invention in the specification. In this case, the CAFC h…
Read More
In In Re: Nuvasive, Inc., the CAFC vacated the PTAB’s Final Decision in an IPR because the PTAB misconstrued the broadest reasonable interpretation of the claim term “lateral, trans-psoas path.”
By way of background, the pat…
Read More
The Federal Circuit, in Nestle USA v. Steuben Foods, vacated a decision by the Patent Trial and Appeal Board (PTAB) in an inter partes review (IPR) for an unreasonably broad interpretation of the term “aseptic.” Notably, where…
Read More
